Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-19-04 | Thyroid Hormone Transport & Metabolism Basic | ETA2023

Repositioning of cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase

Miro Caterina , Sagliocchi Serena , Murolo Melania , Gaetana Cicatiello Annunziata , Nappi Annarita , Di Cicco Emery , Torabinejad Sepehr , Dentice Monica

The iodothyronine deiodinases constitute a family of three selenoenzymes regulating the intracellular metabolism of Thyroid Hormones (THs, T4 and T3) and impacting on several physiological processes, including energy metabolism, development and cell differentiation. The type 1, 2 and 3 deiodinases (D1, D2, and D3), are sensitive, rate-limiting components within the TH axis, and rapidly control TH action in physiological conditions or disease. Notably, several human pathologies...

ea0037ep861 | Thyroid cancer | ECE2015

Our experience in the treatment of Thyr3 and Thyr4 nodules

Bertocchi Elisa , Rio Paolo Del , Viani Lorenzo , Totaro Annarita , Sianesi Mario

Introduction: The Bethesda System 2010 introduced six diagnostic categories and divided follicular proliferation in two risk classes: Thyr3 and Thyr4. In literature about 5–15% of Thyr3 nodules are malignant and the risk of malignancy for Thyr4 is closer to 15–30%. We have analysed our cases surgically treated in recent years.Materials and method: We have prospectively categorised into a dedicated database patients submitted to thyroidectomy at...

ea0011p532 | Endocrine tumours and neoplasia | ECE2006

The value of fluorine-18 fluorodeoxyglucose PET during follow-up of patients with medullary thyroid carcinoma

Lupoli GA , Colarusso S , Panico A , Fonderico F , Nappi F , Marciello F , Gonnella A , Poggiano MR , Nicolai E , Salvatore M , Lupoli G

Introduction: Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) is an innovative method for the detection of primary tumours or metastases of thyroid cancer; however, recurrence or metastases of medullary thyroid carcinoma (MTC) are still difficult to detect.Aim: The objective of this study was to evaluate the clinical use of 18F-FDG PET in patients with MTC.Patients and methods: We enr...

ea0081p475 | Thyroid | ECE2022

Repeating thyroid FNAC: inter-observer agreement among high- and low-volume thyroid services in Naples metropolitan area and correlation with the EU-TIRADS

Scappaticcio Lorenzo , Trimboli Pierpaolo , Iorio Sergio , Arena Stefania , Di Martino Nicole , Palmieri Annarita , Esposito Katherine , Bellastella Giuseppe

Objective: Our institution (University Hospital “L. Vanvitelli“ - Naples, Italy) is a high-volume (HV) center in Naples metropolitan area and many patients are referred there to repeat thyroid fine-needle aspiration cytology (FNAC) after initial FNAC performed in low-volume institutions (LV). The aims of the study were to 1) to examine the inter-observer agreement between HV and LV institutions according to the Italian thyroid cytology system, and 2) explore how the ...

ea0026p74 | Endocrine tumours and neoplasia | ECE2011

In vitro effect of the somatostatin analogue BIM 23704 on cell cycle timecourse in an ovarian carcinoma cell line

de Angelis Cristina , Pivonello Claudia , Cuomo Gaia , Sardo Attilio di Spiezio , Bifulco Guiseppe , Nappi Carmine , Sabbatino Francesco , Cariati Federica , Colao Annamaria , Pivonello Rosario

Ovarian carcinoma (OC) is associated with poor prognosis and low survival rate. Eligible treatment for advanced OC is surgery followed by chemotherapy based on a combination of Platinum and Taxol, but unfortunately long-term outcome of such therapy is disappointing. Moreover, systemic administration of cytotoxic agents is usually accompanied by a series of side effects. On the basis of this evidence, more selective and tumour cell-targeted therapeutic approaches are warranted....

ea0011p531 | Endocrine tumours and neoplasia | ECE2006

Papillary thyroid microcarcinoma: a low risk neoplasia?

Lupoli GA , Colarusso S , Panico A , Fonderico F , Nappi F , Marciello F , Martinelli A , Cuofano P , Lo Calzo F , Vicedomini L , Lupoli G

Introduction: Papillary thyroid micro-carcinoma (PTMC) is a well-differentiated thyroid cancer ≤10 mm in diameter. The recent higher prevalence of PTMC is due to the frequent detection of micro-carcinomas as an incidental finding in surgical specimens, but especially during routine imaging of the neck with highly sensitive techniques.Aim: To review the clinical course of PTMC so to reach its optimal management by adapting therapy and follow-up sche...

ea0056p59 | Adrenal cortex (to include Cushing's) | ECE2018

Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas

Sbardella Emilia , Minnetti Marianna , D'Aluisio Denise , Rizza Laura , Di Giorgio Maria Rosaria , Pofi Riccardo , Giannetta Elisa , Vestri Annarita , Venneri Mary Anna , Morelli Sergio , Lenzi Andrea , Isidori Andrea M

Introduction: Low-grade incomplete post-dexamethasone cortisol suppression in patients with adrenal incidentalomas, recently redefined as possible autonomous cortisol secretion (pACS), has been associated with increased cardiovascular events and mortality. However, prospective studies documenting cardiac abnormalities in these patients are lacking.Methods: In the context of ERGO trial NIH (NCT02611258), between July 2016 and September 2017, 71 consecutiv...

ea0020p22 | Adrenal | ECE2009

Role of chemokines MIP1α and MIP1β in patients with Addison's disease isolated or associated to autoimmune thyroid disease

De Bellis Annamaria , Pane Elena , Battaglia Marina , Ruocco Giuseppe , Tirelli Gilda , Bellastella Giuseppe , Agostino Sinisi Antonio , Susan Costantini , Capone Francesca , Aiello Talamanca Annarita , Calemma Rosa , Bizzarro Antonio , Bellastella Antonio

High levels of macrophage inflammatory proteins (MIP1α and MIP1β), related to the recruitment of Th1 and Th2 cells, respectively, have been evidenced in some organ and non organ-specific autoimmune diseases. CXCL10/IP10 has been evidenced in patients with autoimmune thyroid disease (ATD) and in Addison’s disease (AD); MIP1α and MIP1β chemokines have not been so far evaluated in these diseases.Aim: To evaluate plasmatic levels MIP...